DSGNDesign Therapeutics, Inc.

$569M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$5,000

Operating Income

-$9M

Net Income

-$8M

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$450,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$48M

Stockholders' Equity

-$11M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$834	-100.0%
Gross Profit	-$5,000	-$820	-509.8%
Operating Income	-$9M	-$2M	-348.4%
Net Income	-$8M	-$2M	-304.5%

DSGN FY 2020 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena